RON SCHAFER: Open Payments
NPI 1497806038 · MOUNT AYR, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 30 payments from 15 companies in 2025. Trend: 2023 $526 · 2024 $1,675 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| Organogenesis Inc. | 3 | $130 |
| Verona Pharma, Inc. | 4 | $64 |
| PFIZER INC. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| Viatris Specialty LLC | 2 | $28 |
| ABIOMED | 1 | $20 |
| Radius Health, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: VIA MATRIX, Ohtuvayre, FARXIGA, NURTEC ODT, YUPELRI, NUSHIELD, Ozempic, ELIQUIS.
Industry payments across IA — which companies pay providers there.
